Tag: COVID-19

FDA issues EUA for J&J’s single-dose COVID-19 vaccine

Editor's Note The Food and Drug Administration (FDA) on February 27 issued an emergency use authorization (EUA) for Johnson & Johnson’s single-dose COVID-19 vaccine, making it the third coronavirus vaccine approved for use in the US. The vaccine can be administered to people ages 18 and older. Vaccinations will begin…

Read More

By: Judy Mathias
March 1, 2021
Share

Association of COVID-19 positive antibody test with future risk of infection

Editor's Note This study, funded by the National Cancer Institute, National Institutes of Health, Bethesda, Maryland, finds that individuals who are antibody positive for COVID-19 based on commercial assays, versus those who are antibody negative, are at decreased risk of future COVID-19 infection. In this analysis of 3,257,478 patients with…

Read More

By: Judy Mathias
February 25, 2021
Share

Nearly 4M J&J vaccine doses to be delivered next week, if EUA granted

Editor's Note Up to 4 million doses of the Johnson & Johnson (J&J) single-dose COVID-19 vaccine will be delivered to states, community health centers, and pharmacies next week, if the vaccine receives Emergency Use Authorization (EUA) from the Food & Drug Administration (FDA), the February 24 The Hill reports. An…

Read More

By: Judy Mathias
February 25, 2021
Share

Significant proportion of hospitalized COVID-19 patients are asymptomatic

Editor's Note This study from the University of Louisville School of Medicine, Louisville, Kentucky, shows that the proportion of asymptomatic patients admitted to the hospital with COVID-19 is significant, and why universal testing is important to prevent hospital-acquired infection. Of 2,882 patients admitted to the hospital, 103 were COVID-19 positive.…

Read More

By: Judy Mathias
February 25, 2021
Share

Total hospital admissions down 8.5%

Editor's Note An electronic medical record (EMR) data analysis by Epic Health Research Network for the Kaiser Family Foundation finds that from March through December 2020, hospital admissions were 8.5% below predictions because of COVID-19. The analysis, which is based on Epic’s EMR data on all inpatient admissions from December…

Read More

By: Judy Mathias
February 23, 2021
Share

FDA, USDA, CDC say COVID-19 can’t spread via food, packaging

Editor's Note The Food and Drug Administration (FDA), US Department of Agriculture (USDA), and Centers for Disease Control and Prevention (CDC), on February 18, issued a statement saying there is no epidemiological evidence out of more than 100 million cases globally that COVID-19 can be transmitted through food or food…

Read More

By: Judy Mathias
February 23, 2021
Share

Steep decline in routine vaccinations in older adults during COVID-19

Editor's Note This Centers for Disease Control and Prevention (CDC) study finds a huge drop in routine vaccinations in Medicare beneficiaries during the COVID-19 pandemic. Comparing data from January to July 2019 and January to July 2020, declines of 70% to 89% in routine vaccinations were seen in mid-April 2020.…

Read More

By: Judy Mathias
February 23, 2021
Share

Adverse mental health symptoms, substance use, suicide ideation during COVID-19

Editor's Note This follow-up survey of 5,285 US adults, which was completed in September 2020, finds that overall: 1,710 (33.0%) reported anxiety or depression symptoms 1,536 (29.6%) reported COVID-19 related trauma- and stressor-related disorder symptoms 781 (15.1%) reported increased substance use 618 (11.9%) reported having seriously considered trying to kill…

Read More

By: Judy Mathias
February 22, 2021
Share

Johns Hopkins professor Marty Makary, MD, predicts herd immunity by April

Editor's Note In a February 18 Wall Street Journal op-ed, Marty Makary, MD, a surgeon and a professor at the Johns Hopkins School of Medicine and Bloomberg School of Public Health, predicts that the US will have herd immunity to COVID-19 by April. He notes that COVID-19 cases have dropped…

Read More

By: Judy Mathias
February 22, 2021
Share

Joint Commission updates information on offsite surveys, reviews

Editor's Note The Joint Commission, on February 17, announced that it had updated its information on offsite (ie, virtual) surveys and reviews. In response to COVID-19, the Joint Commission stopped most onsite surveys and reviews from March 16 to May 31, 2020, and they developed processes for offsite events. As…

Read More

By: Judy Mathias
February 18, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat